4JDA image
Deposition Date 2013-02-24
Release Date 2013-07-24
Last Version Date 2023-11-08
Entry Detail
PDB ID:
4JDA
Title:
Complex structure of abscisic acid receptor PYL3 with (-)-ABA
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.26
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 65
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Abscisic acid receptor PYL3
Gene (Uniprot):PYL3
Chain IDs:A, B, C, D
Chain Length:192
Number of Molecules:4
Biological Source:Arabidopsis thaliana
Ligand Molecules
Primary Citation
Structural Insights into the Abscisic Acid Stereospecificity by the ABA Receptors PYR/PYL/RCAR
Plos One 8 e67477 e67477 (2013)
PMID: 23844015 DOI: 10.1371/journal.pone.0067477

Abstact

The phytohormone abscisic acid ((+)-ABA) plays a key role in many processes. The biological and biochemical activities of unnatural (-)-ABA have been extensively investigated since 1960s. However, the recognition mechanism by which only a few members among PYR/PYL/RCAR (PYLs) family can bind (-)-ABA remains largely unknown. Here we systematically characterized the affinity of PYLs binding to the (-)-ABA and reported the crystal structures of apo-PYL5, PYL3-(-)-ABA and PYL9-(+)-ABA. PYL5 showed the strongest binding affinity with (-)-ABA among all the PYLs. PYL9 is a stringently exclusive (+)-ABA receptor with interchangeable disulfide bonds shared by a subclass of PYLs. PYL3 is a dual receptor to both ABA enantiomers. The binding orientation and pocket of (-)-ABA in PYLs are obviously different from those of (+)-ABA. Steric hindrance and hydrophobic interaction are the two key factors in determining the stereospecificity of PYLs binding to (-)-ABA, which is further confirmed by gain-of-function and loss-of-function mutagenesis. Our results provide novel insights of the bioactivity of ABA enantiomers onto PYLs, and shed light on designing the selective ABA receptors agonists.

Legend

Protein

Chemical

Disease

Primary Citation of related structures